A novel thiazolidinedione MCC-555 down-regulates tumor necrosis factor-α-induced expression of vascular cell adhesion molecule-1 in vascular endothelial cells

Atherosclerosis

Volumn 182, Issue 1, 2005, Pages 71-77

  Kurebayashi, Shogo ^a   Xu, Xin ^a   Ishii, Shinichi ^b   Shiraishi, Muneshige ^b   Kouhara, Haruhiko ^a   Kasayama, Soji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Adhesion molecules; Atherosclerosis; Endothelium; Thiazolidinediones; Vascular biology

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NETOGLITAZONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; AORTA; ARTICLE; CELL ADHESION; DOWN REGULATION; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

AORTA; CELL ADHESION; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; NF-KAPPA B; PPAR ALPHA; PPAR GAMMA; PROMOTER REGIONS (GENETICS); THIAZOLES; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 23944447078     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.02.004     Document Type: Article

References (30)

1. J.M. Lehmann, L.B. Moore, and T.A. Smith-Oliver An anti-diabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator- activated receptor γ (PPARγ) J Biol Chem 270 1995 12953 12956
2. C. Dreyer, G. Krey, and H. Keller Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors Cell 68 1992 879 887
3. T.M. Willson, J.E. Cobb, and D.J. Cowan The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the anti-hyperglycemic activity of thiazolidinediones J Med Chem 39 1996 665 668
4. C. Jiang, A.T. Ting, and B. Seed PPAR-γ agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
5. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation Nature 391 1998 79 82
6. N. Marx, U. Schonbeck, M.A. Lazar, P. Libby, and J. Plutzky Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells Circ Res 83 1998 1097 1103
7. K. Murao, H. Imachi, and A. Momoi Thiazolidinedione inhibits the production of monocyte chemoattractant protein-1 in cytokine-treated human vascular endothelial cells FEBS Lett 454 1999 27 30
8. S.M. Jackson, F. Parhami, and X.P. Xi Peroxisome proliferator-activated receptor-activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction Arterioscler Thromb Vasc Biol 19 1999 2094 2104
9. J. Minamikawa, S. Tanaka, M. Yamauchi, D. Inoue, and H. Koshiyama Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes J Clin Endocrinol Metab 83 1998 1818 1820
10. M.I. Cybulsky, and MA. Gimbrone Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis Science 251 1991 788 791
11. M.P. Bevilacqua, R.M. Nelson, G. Mannori, and O. Cecconi Endothelial-leukocyte adhesion molecules in human disease Annu Rev Med 45 1994 361 378
12. M.I. Cybulsky, K. Iiyama, and H. Li A major role for VCAM-1, but not ICAM-1, in early atherosclerosis J Clin Invest 107 2001 1255 1262
13. T. Caulin-Glaser, C.A. Watson, R. Pardi, and J.R. Bender Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expression J Clin Invest 98 1996 36 42
14. M. Otsuki, H. Saito, and X. Xu Progesterone, but not medroxyprogesterone, inhibits vascular cell adhesion molecule-1 expression in human vascular endothelial cells Arterioscl Thromb Vasc Biol 21 2001 243 248
15. J. Gille, L.L.L. Paxton, T.J. Lawley, S.W. Caughman, and R.A. Swerlick Retinoic acid inhibits the regulated expression of vascular cell adhesion molecule-1 by cultured dermal microvascular endothelial cells J Clin Invest 99 1997 492 500
16. N. Marx, G.K. Sukhova, T. Collins, P. Libby, and J. Plutzky PPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells Circulation 99 1999 3125 3131
17. X. Xu, M. Otsuki, and H. Saito PPARα and GR differentially down-regulate the expression of nuclear factor-κB-responsive genes in vascular endothelial cells Endocrinology 142 2001 3332 3339
18. R. Upton, P.S. Widdowson, S. Ishii, H. Tanaka, and G. Williams Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione MCC-555 Br J Pharmacol 125 1998 1708 1714
19. L. Pickavance, P.S. Widdowson, and P. King The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment Br J Pharacol 125 1998 767 770
20. M.J. Reginato, S.T. Bailey, and S.L. Krakow A potent anti-diabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties J Biol Chem 273 1998 32679 32684
21. S. Ishii, M. Shiraishi, K. Sasaki, and M. Kawai A novel PPAR agonist, MCC-555, ameliorates endothelial cell dysfunction Second International Symposium on PPARs: From Basic Science to Clinical Applications Florence, Italy March 19-22, 2003 (Abstract)
22. T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs: from orphan receptors to drug discovery J Med Chem 43 2000 527 550
23. R. De Caterina, P. Libby, and H.B. Peng Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines J Clin Invest 96 1995 60 68
24. 2 analogue, beraprost sodium, on vascular cell adhesion molecule-1 expression in human vascular endothelial cells and circulating vascular cell adhesion molecule-1 level in patients with type 2 diabetes mellitus Metabolism 52 2003 192 198
25. M. Takagi, S. Kasayama, and T. Yamamoto Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells J Bone Miner Res 12 1997 439 446
26. A.S. Neish, A.J. Williams, H.J. Palmer, M.Z. Whitley, and T. Collins Functional analysis of the human vascular cell adhesion molecule-1 promoter J Exp Med 176 1992 1583 1593
27. B. Staels, J. Dallongeville, and J. Auwerx Mechanism of action of fibrates on lipid and lipoprotein metabolism Circulation 98 1998 2088 2093
28. W.R. Oliver Jr., J.L. Shenk, and M.R. Snaith A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport Proc Natl Acad Sci USA 98 2001 5306 5311
29. Y. Rival, N. Beneteau, and T. Taillandier PPARα and PPARδ activators inhibit cytokine-induced nuclear translocation of NF-κB and expression of VCAM-1 in EAhy926 endothelial cells Eur J Pharmacol 435 2002 143 151
30. P. Gaede, P. Vedel, and N. Larsen Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 2003 383 393